Broadly, tissue regeneration is achieved in two ways: by proliferation of common differentiated cells and/or by deployment of specialized stem/progenitor cells. Which of these pathways applies is both organ-and injury-specific 1-4 . Current models in the lung posit that epithelial repair can be attributed to cells expressing mature lineage markers [5] [6] [7] [8] . By contrast, here we define the regenerative role of previously uncharacterized, rare lineage-negative epithelial stem/ progenitor (LNEP) cells present within normal distal lung. Quiescent LNEPs activate a DNp63 (a p63 splice variant) and cytokeratin 5 remodelling program after influenza or bleomycin injury in mice. Activated cells proliferate and migrate widely to occupy heavily injured areas depleted of mature lineages, at which point they differentiate towards mature epithelium. Lineage tracing revealed scant contribution of pre-existing mature epithelial cells in such repair, whereas orthotopic transplantation of LNEPs, isolated by a definitive surface profile identified through single-cell sequencing, directly demonstrated the proliferative capacity and multipotency of this population. LNEPs require Notch signalling to activate the DNp63 and cytokeratin 5 program, and subsequent Notch blockade promotes an alveolar cell fate. Persistent Notch signalling after injury led to parenchymal 'microhoneycombing' (alveolar cysts), indicative of failed regeneration. Lungs from patients with fibrosis show analogous honeycomb cysts with evidence of hyperactive Notch signalling. Our findings indicate that distinct stem/progenitor cell pools repopulate injured tissue depending on the extent of the injury, and the outcomes of regeneration or fibrosis may depend in part on the dynamics of LNEP Notch signalling.
Influenza infection challenges pulmonary regenerative capacity owing to the widespread ablation of epithelial cells in substantial areas of lung 8 (Extended Data Fig. 1g, h) . A robust expansion of regenerative cytokteratin-5-positive (Krt5 1 ) cells in the lung parenchyma after influenza infection has been observed in mice 8 , which we confirmed (Extended Data Fig. 1 ). In addition, we directly observed migration (Supplementary Videos 1, 2 and 3) and identified coexpression of integrin a 6 b 4 (Extended Data Figs 1 and 2) . These cells also appear variably after bleomycin injury, in which approximately one-third of the Krt5 1 cells resolved into type II pneumocytes by 50 days after injury (Extended Data Fig. 3) . A cellular origin and mechanistic framework for expansion after influenza, and potential parallels in human lung injury, remain unknown.
To define the cell of origin, we lineage-traced mature cell types implicated in epithelial repair. Krt5 1 cells appearing by day 11 after influenza infection were essentially completely untraced using Clara cell-specific protein (CC10) and surfactant protein C (SPC) Cre-recombinase drivers (CC10-CreERT2 and SPC-CreERT2, respectively, containing tamoxifeninducible Cre-modified oestrogen receptor fusion proteins) ( Fig. 1b-e and Extended Data Fig. 1i ). Analysis at 7-8 days after injury confirmed mutual exclusivity of CC10-CreERT2-labelled and Krt5 1 cells (Fig. 1b) . Conflicting results in other reports are probably caused by tamoxifen persistence (Supplementary Discussion and Extended Data Fig. 4 ).
A small fraction (13%) of expanded Krt5 1 cells bear the Krt5-CreERT2 lineage label ( Fig. 1f, g) , raising the possibility that tracheal basal cells might migrate distally during injury. We transplanted sections of fluorescent trachea into syngeneic animals and a non-fluorescent left lung into a fluorescent mouse 9 . Abundant Krt5 1 cells arose after infection but none were fluorescent ( Fig. 1h and Extended Data Fig. 1j , k). Upperairway basal cells therefore do not contribute to this phenomenon and instead implicate a lineage-negative epithelial progenitor (LNEP) as the major source of DNp63 1 and Krt5 1 cells.
To characterize quiescent LNEPs, we used integrin b 4 expression in CC10-CreERT2 mice to segregate LNEPs from club cells in uninjured lungs ( Fig. 2a ) and confirmed minimal expression of mature lineage markers (Extended Data Fig. 5c ). The CC10 2 b 4 1 (LNEP-containing) population uniquely expressed DNp63 (Extended Data Fig. 5c ). DNp63 1 cells were identified in situ scattered sporadically throughout distal airways ( Fig. 2c ). These cells did not express detectable Krt5 protein (Extended Data Fig. 5a ). In a total of 65 small airways examined in two mice, we identified 24 DNp63 1 cells. Only 7 of the 24 cells were labelled in Krt5-CreERT2 mice ( Fig. 2c and Extended Data Fig. 5a ), probably explaining the small fraction of post-injury Krt5 1 cells bearing the Krt5-CreERT2 lineage label ( Fig. 1f, g) .
Given the infrequency of DNp63 1 cells, we suspected progenitor activity of the CC10 2 b 4 1 population might be restricted to a smaller subset. Immunostaining revealed multicilia in 78% of this population, whereas DNp63 1 cells were less than 1% (Extended Data Fig. 5b ). To address this heterogeneity, we performed single-cell RNA sequencing (RNA-seq) on CC10 2 b 4 1 cells and on rare Krt5-CreERT2-labelled cells, a subset of this population (Fig. 2i ). The DNp63 transcript was detected in several cells in the CC10 2 b 4 1 population ( Fig. 2b , red circle, far left) as well as the Krt5-traced cells ( Fig. 2b , green triangle). Analysis of variance (ANOVA) comparison between putative LNEPs (Krt5-traced cells combined with all p63-expressing cells) and the remaining cells revealed enrichment of ,900 genes (.2-fold change, .1 FPKM, P # 0.05) in the LNEP group (Supplementary Data 1). We note enrichment for pluripotency-associated transcription factors (Myc and Klf4) in the LNEP group ( Fig. 2b) , while many genes enriched in the remaining cells ( Fig. 2b , top rows, Supplementary Data 2) are known markers of ciliated cells 10 . Surprisingly, DNp63 1 CC10 2 b 4 1 cells most closely related to the Krt5traced cells also expressed cilia-associated genes (Fig. 2b , denoted by asterisk). Cytospins of CC10 2 b 4 1 cells revealed primary cilia on DNp63 1 cells and additional cells without discernible DNp63 (Fig. 2c , right), indicating that the LNEP profile extends to a larger fraction of DNp63-low or -negative cells.
To assess the potential of LNEPs in vivo, we devised a transplantation assay by which ,10 5 fluorescent CC10 2 b 4 1 cells were delivered orthotopically into influenza-injured mice (Fig. 2d ). Seeded LNEPs developed into multicellular structures in two patterns seemingly dependent on location: areas of type II cells that were virtually indistinguishable from surrounding endogenous type II cells (Extended Data Fig. 6a , b, h), and engraftments expressing Krt5 (Extended Data Fig. 6a , c) and CC10 (Extended Data Fig. 6g ) near endogenous Krt5 1 CC10 1 structures. b 4 2 type II cells engrafted infrequently in small clusters (,8 cells), and expressed only alveolar markers (Extended Data Fig. 6i ). CC10 1 cells could engraft but exhibited scant differentiation, even losing CC10 expression (Extended Data Fig. 6j , k). Transplantation of multi-ciliated cells resulted in only occasional persistence of single cells without structures (Extended Data Fig. 6l ), consistent with their lack of progenitor properties 11,12 .
Transplantation of mixed enhanced green fluorescent protein (eGFP)labelled and tdTomato-expressing LNEPs demonstrated engraftments to be largely non-overlapping ( Fig. 2e ) and highly proliferative (Extended Data Fig. 6e ), arguing for near-clonal expansion. Although mature type II cells do not express integrin b 4 (ref. 13 ), clones derived from donor LNEPs exhibited b 4 and SPC co-expression 5 days after transplant (Extended Data Fig. 6e ), confirming their LNEP origin. These data demonstrate multipotency of LNEPs as well as the viability of orthotopic cell transplantation as a functional tool.
We interrogated the RNA-seq analysis and identified enrichment for CD14 in DNp63 1 CC10 2 b 4 1 cells ( Fig. 2b, asterisk) . In combination with CD200, which further selects against multi-ciliated cells (Extended Data Fig. 5e ), CD14 1 cells were isolated and transplanted. b 4 1 CD200 1 CD14 1 cells (,3,000) ( Fig. 2f ) phenocopied the larger (150,000) CC10 2 b 4 1 population (Fig. 2g , h and Extended Data Fig. 7a -c), validating this small population as the active LNEPs. Using a complementary approach, distal Krt5-CreERT2-labelled DNp63 1 cells within the LNEP fraction were transplanted (1,000 cells per mouse) ( Fig. 2i ). Multipotency was again observed, although we noted many fewer SPCexpressing cells (Fig. 2j , k and Extended Data Fig. 7d, e ). We posit that isolation using Krt5-driven Cre enriches for LNEPs that have undergone partial commitment to the Krt5 program, whereas surface-markerbased selection represents a less biased approach. This is consistent with lineage analysis (Fig. 1h ) indicating Krt5-CreERT2-traced cells can only account for a small fraction of the Krt5 1 expansion. Accordingly, LNEPs cultured ex vivo did not express Krt5 even when treated with various trophic/morphogenic factors ( Supplementary Table 2 ). However, bronchoalveolar lavage fluid (BALF) from injured mice induced marked proliferation and Krt5 expression. A total of 77 6 13% (mean 6 s.d.) of colonies treated with the BALF stained positive for Krt5 ( Fig. 3a-d) , whereas type II cells treated with the same BALF did not respond.
Although the active principle(s) in injury BALF is uncertain, a screen of pathway inhibitors implicated a critical role of Notch. The c-secretase inhibitor DAPT in conjunction with active BALF attenuated intensity and reduced the Krt5 1 colony fraction (22.7 6 13%) ( Fig. 3c, d ). This prompted us to analyse Notch activity in vivo. Notch1 intracellular domain (ICD) and the canonical Notch signalling target Hes1 were evident in the nucleus of parenchymal Krt5 1 cells after influenza ( Fig. 3e , f). Notch activity was further validated using a Notch reporter mouse (Cp-eGFP) (Extended Data Fig. 8a, b ). When DAPT was administered to mice after influenza, the fraction of lung area bearing Krt5 1 cells by day 11 was markedly reduced ( Fig. 3g and Extended Data Fig. 7h ).
During development, Notch signalling is known to suppress alveolar differentiation in both the lung and the mammary gland 14, 15 . When LNEPs were cultured in the presence of c-secretase inhibitors, we observed strong induction of SPC expression, further promoted by 3-isobutyl-1-methylxanthine (IBMX) 16 (Fig. 3h, i) . Therefore, persistent Notch signalling prevents alveolar differentiation, whereas removal of this signal promotes maturation towards type II cells. This result proved 
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relevant to the long-term outcome of regeneration in the influenza injury model.
Although regions of relatively normal histology bearing the Krt5-CreERT2 trace develop after resolution of bleomycin injury (Extended Data Fig. 3e ), we were surprised to find few traced SPC 1 type II cells after influenza (Extended Data Fig. 8e ). Instead, large regions of Krt5-Cre-traced epithelial cysts were present in all mice examined between days 52 and 200 after injury (n 5 7 mice) ( Fig. 4a ). These cysts consisted of CC10 1 cells, scattered Krt5 1 cells, otherwise nondescript epithelial cells, but very few SPC 1 cells ( Fig. 4a and Extended Data Fig. 8c-e ), raising the possibility of ongoing Notch activity in cystic epithelium. Strong Hes1 expression persisted in Krt5-CreER-traced cyst-derived cells indefinitely ( Fig. 4b and Extended Data Fig. 8f ), whereas it is normally undetectable in alveolar epithelium (Extended Data Fig. 8g ). The same correlation was observed in transplant experiments: LNEP-derived Krt5 1 and CC10 1 areas exhibited strong Hes1 expression, whereas it was low or absent in areas of type II cell differentiation (Extended Data Fig. 6b-d ). Notch antagonism in vivo via intranasal delivery of dibenzazepine (DBZ; in conjunction with dexamethasone and IBMX) resulted in a significant increase in the number of cyst-derived SPC 1 cells (12.3% versus 1.6%) ( Fig. 3j-l) .
Persistent cysts bear a strong resemblance to micro-honeycombing in the lungs of patients with idiopathic pulmonary fibrosis (IPF) ( Fig. 4c, d ). These lungs (n 5 10) showed almost all cystic epithelia were comprised of KRT5 1 cells surrounded by either additional metaplastic KRT5 1 cells or pseudostratified epithelium with ectopic but otherwise typical basal cells 17 . Distinct foci of hyperplastic SPC 1 cells were also present. Notch activity correlated with KRT5 1 cysts but was absent in most hyperplastic SPC 1 cells (Fig. 4d-f and Extended Data Fig. 9a-d ) and in normal alveolar regions (Extended Data Fig. 9k ).
In lungs from patients with scleroderma (n 5 7), fibrotic areas displayed the IPF pattern of persistent KRT5 1 and HES1 1 cystic structures (Extended Data Fig. 9e , g, h). However, in three less-fibrotic specimens, we observed extensive double-positive KRT5 1 and SPC 1 cells lining LETTER RESEARCH alveoli ( Fig. 4g and Extended Data Fig. 9f ). Although the origin of this KRT5 1 expansion is uncertain in humans, we note DNp63 1 KRT5 2 cells in normal terminal airways (Extended Data Fig. 9i ), analogous to LNEPs in mice.
These experiments identify a rare, undifferentiated epithelial population that is the major responder in distal lung after severe damage (Extended Data Fig. 10a ). Notch signalling modulates the quiescence, activation and differentiation state of murine LNEPs (Extended Data Fig. 10b) , providing a signalling model to frame the dynamic aspects of LNEP function. The persistently abnormal parenchymal structures that derive from LNEPs after influenza infection represent a failed regenerative process, promoted at least in part by ongoing Notch activity. The striking parallels to the currently inexplicable micro-honeycombing that characterizes progressive fibrotic lung disease, including hyperactive Notch, suggest inappropriate Notch signalling may also be a major contributor to failed regeneration in chronic lung disease.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
Supplementary Information is available in the online version of the paper.
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METHODS
Animals.
SPC-CreERT2 (Sftpc tm1(cre/ERT2,rtTA)Hap ), Krt5-CreERT2 (Krt5 tm1.1(cre/ERT2)Blh ), CC10-CreERT2 (Scgb1a1 tm1(cre/ERT)Blh ), FoxJ1-CreERT2 (Tg (Foxj1-cre/ERT2)1Blh ) and Cp-eGFP (Tg(Cp-EGFP)25Gaia) mice are previously described 13, [18] [19] [20] . All of these strains were bred to either mTmG (Gt(ROSA)26Sor tm4(ACTB-tdTomato,-EGFP)Luo ) 21 or Ai14-tdTomato (Gt(ROSA) 26Sor tm14(CAG-tdTomato)Hze ) 22 mice to generate mice expressing a fluorophore in Creexpressing cells. SPC-CreERT2, Krt5-CreERT2 and CC10-CreERT2 mice were developed in a 129 background and backcrossed to C57BL6 for at least three generations. For transplant experiments, mTmG and/or Ub-GFP (Tg(UBC-GFP) 30Scha) 23 were used for donor cells. For all experiments, 6-8-week-old animals of both sexes were used in equal proportions. Investigators were not blinded to mouse identity. All studies were approved by University of California, San Francisco (UCSF) Institutional Animal Care and Use Committees (IACUC), protocol AN088356-03. All animal studies used a minimum of three mice per group with the exception of DBZ (see below).
For lineage analysis of the cell of origin of Krt5 1 cells, mice were administered three doses (Krt5-CreERT2) or five doses (SPC-CreERT2 and CC10-CreERT2) of 0.25 mg g 21 body weight tamoxifen in 50 ml corn oil. A chase period of .21 days was used to insure the absence of residual tamoxifen before injury. Injury (influenza, bleomycin). Mice were administered 280 focus-forming units (FFU) of influenza A/H1N1/Puerto Rico/8/34 (PR8) intranasally. PR8 virus dissolved in 30 ml PBS was pipetted onto the nostrils of heavily anaesthetized mice (visual confirmation of agonal breathing), whereupon mice aspirated the fluid directly into their lungs. The mice were allowed to recover and weighed twice a week. For experiments analysing the lineage fate of Krt5 1 cells, a single dose of 0.125 mg g 21 body weight tamoxifen was administered at day 10 after PR8 infection.
Infective viral particles were assayed by inoculation of either stock virus or homogenate (in 1 ml PBS) of left lung, spleen and brain onto 96-well plates of confluent MDCK cells. After 1 h, samples were decanted and replaced with serum-free media containing modified trypsin (L-(tosylamido-2-phenyl) ethyl chloromethyl ketone (TPCK)-treated) at 100 mg ml 21 . Fifteen hours later, the cells were fixed in 100% methanol, and then subjected to indirect immunocytochemistry using Millipore mouse anti-influenza A (MAB 8257) at 1.25 mg ml 21 , followed by Vector 102 biotinylated horse anti-mouse, and the biotin/avidin system (PK-4002) with diaminobenzidine as a chromogen. Samples were processed in triplicate over dilutions, and foci were counted in wells that yielded 30-100 discrete foci.
Bleomycin (1.7 U kg 21 body weight) was administered intratracheally. Mice were weighed twice a week. For lineage tracing Krt5 1 cells after bleomycin, a single dose of 0.125 mg g 21 body weight tamoxifen was administered at day 17 after bleomycin. Treatment of animals with c-secretase inhibitors. For DAPT administration, mice received 50 mg kg 21 body weight DAPT in 20 ml dimethylsulphoxide (DMSO) per intraperitoneal injection, for the indicated periods. For intranasal DBZ administration, 30 mmol kg 21 body weight DBZ was suspended in 50 ml sterile PBS and sonicated in a Bioruptor UCD-200 for 15 min total, 30 s intervals on ice. In DBZ experiments, both DBZ and vehicle group also received 2.5 mg g 21 body weight dexamethasone (Sigma) in the intranasal solution and 10 mg kg 21 IBMX (Sigma) intraperitoneally daily. Both DAPT and DBZ were obtained from Toronto Research Chemicals. More than 7,500 Krt5-CreERT2-labelled cells were quantified for SPC expression in at least two individual lobes from each mouse. Orthotopic lung transplantation. Left lung transplants were carried out using the method described previously 24 . The donor animal was anaesthetized and injected with heparin (50 U) immediately before perfusion of the lung vasculature with 5 ml of ice-cold Perfadex solution (Xvivo Perfusion), clamping of the hilar structures, and removal from the donor animal. The left lung was transplanted into the recipient animal using the cuff anastomosis technique. Orthotopic tracheal transplantation. The donor animal was anaesthetized and with the aid of microscopic dissection, a segment of trachea composed of 5-7 tracheal rings was removed. The recipient animal was anaesthetized and the donor trachea was interposed using proximal and distal anastomoses 9 . Immunofluorescence analysis of tissue. After euthanasia, lungs were either immediately inflated with OCT and flash frozen or inflated with 4% paraformaldehyde (PFA) and fixed for 1 h at room temperature and subsequently embedded in OCT. Sections (7 mm) were cut on a cryostat, with fresh-frozen tissue immediately fixed for 5 min in 4% paraformaldehyde at room temperature. All sections were subsequently incubated for 3 3 10-min intervals with 1 mg ml 21 sodium borohydride (Sigma) in PBS to reduce aldehyde-induced background fluorescence. Slides were subsequently blocked $1 h in PBS plus 1% bovine serum albumin (Affymetrix), 5% nonimmune horse serum (UCSF Cell Culture Facility), 0.1% Triton X-100 (Sigma) and 0.02% sodium azide (Sigma). Slides were incubated overnight in primary antibodies listed below, diluted in block solution. Slides were washed three times with PBS plus 0.1% Tween 20, and incubated with secondary antibodies (typically Alexa Fluor conjugates, Life Sciences) at a 1:2,000 dilution $1 h. Finally, slides were again washed, incubated with 1 mM DAPI for 5 min, and mounted using Prolong Gold (Life Sciences).
The following antibodies were used: rabbit anti-proSPC (1:3,000; Millipore, AB3786), goat anti-proSPC (1:2,000; Santa Cruz, M-20), goat anti-CC10 (1:10,000, a gift from B. Stripp), rabbit anti-Krt5 (1:1000; Covance, PRB-160P), chicken anti-Krt5 (1:1,000; Covance, SIG-3475), rabbit anti-DNp63 (1:100; Biolegend, POLY6190), rat anti-CD45 (1:200, BD 30-F11), sheep anti-eGFP (1:500; Pierce, 10396164), rabbit anti-phospho histone H3 (1:500; Millipore, 06-570), rabbit anti-Hes1 (1:1,000; Cell Signaling, D6P2U), rabbit anti-activated Notch1 (1:1,000; Abcam, ab8925), mouse anti-acetylated tubulin (1:500, Sigma, 6-11B-1). Quantification of lineage tracing. Samples were prepared for immunofluorescence staining. Quantification at day 11 after influenza is the result of counting .2,900 cells (CC10 trace), .4,000 cells (SPC trace), or .1,300 (Krt5 trace) from at least three mice per genotype. Cells were counted from over five sections per mouse and included at least three individual lobes. Mutual exclusivity of CC10-traced and Krt5 1 cells at days 7-8 was determined with a smaller sample size, n 5 2 mice, 12 Krt5 1 airways, .500 cells examined. Only mice possessing the appropriate genotype were used in studies. Epithelial cell isolation and flow cytometry. Lung epithelial cells were isolated as previously described 13 , with the following modifications. After installation with agarose and subsequent hardening by a brief incubation on ice, each lobe was cut away from the mainstem bronchi. The proximal-most quarter of each lobe surrounding the bronchi was then cut away to minimize the inclusion of basal cells in the cell preparation, and the previous protocol was followed from this point on.
For FACS analysis, single-cell preparations were incubated for 30-45 min at 4 uC with the following primary antibodies: phycoerythrin (PE), Alexa Fluor 488, or BV421-conjugated rat anti-mouse EpCAM (1:500; Biolegend, G8.8), Alexa Fluor 647 or PE-conjugated rat anti-mouse integrin b 4 (1:75; BD, 450-9D), Alexa 647conjugated CD200 (1:100, Biolegend, OX-90), and PE/Cy7-conjugated CD14 (1:100, Biolegend, Sa14-2). Antibody incubations were done in DMEM (without phenol red) plus 2% FBS, and cells were washed twice with PBS after antibody incubations. Sorting and analysis was performed on BD FACS Aria cytometers. Orthotopic cell transplantation. Recipient C57BL/6 mice were infected with PR8 (see Animals). At 9 days after infection, donor cells were sorted from mTmG or Ub-GFP mice (Animals) and resuspended in 50 ml sterile PBS. Recipient mice received cell solution intranasally as described above for influenza administration. The total number of b 4 1 cells ranged from 150,000 to 350,000 per transplant (n 5 6), and equivalent numbers of b 4 2 cells were always transplanted into injured littermates for comparison. For transplantation of Krt5-CreERT2-labelled cells, 1,000 cells were transplanted per recipient (n 5 2). For b 4 1 CD14 1 CD200 1 cell transplants, 3,000-10,000 cells were transplanted per mouse (n 5 3). FoxJ1-CreERT2labelled or CC10-CreERT2-labelled cell transplants were performed in n 5 3 or 4 mice each, respectively (1 3 10 5 -3 3 10 5 cells per mouse). Endpoint analysis was performed at day 21 after infection unless otherwise noted. For analysis of proliferation, recipient mice were administered 50 mg kg 21 body weight Edu (Santa Cruz) in PBS daily. Edu was detected with Click-iT EdU Alexa Fluor 488 Imaging Kit (Invitrogen). Primary cell culture. Isolated primary lung epithelial cells were plated and cultured on Matrigel as follows. Eight-well chamber slides were coated with 150 ml Matrigel per well, allowed to solidify at 37 uC, and then equilibrated with SABM (Lonza) for at least 30 min before cell plating. A total of 15,000-40,000 cells were plated in each well of and maintained in 'baseline' media consisting of SAGM (Lonza) supplemented with 5% charcoal-stripped FBS and 10 ng ml 21 KGF (FGF-7, Peprotech). Other growth factors were included in the media only when indicated and are summarized in Supplementary Table 2. BALF was collected from injured animals for cell culture as follows. Euthanized mice were intratracheally intubated before cardiac perfusion and 1 ml of baseline media was lavaged. The lungs were repeatedly lavaged with the media at least three times. BALF was then centrifuged three times for 5-min spins at 1,500g to remove the cells and other debris. Clarified BALF was finally filtered through a 0.25-mm Spin-X filter (Sigma) to remove any additional debris and to ensure a cell-free preparation. BALF prepared in this way was either added to cells immediately or frozen in aliquots at 280 uC and added to cultured cells without dilution. Long-term cell culture. Cells isolated as above were maintained in SAGM as above, with the addition of 10 mM Y-27632 (Sigma) and 50 ng ml 21 murine noggin (Peprotech). Cells were passaged every 7-10 days by initial incubation with 25 U ml 21 dispase at 37 uC for 20 min to liberate colonies. Single-cell dissociation was performed by additional 10-min incubation with 2 mM EDTA in PBS in combination with mechanical disaggregation by pipetting. c-secretase treatment of LNEPs in vitro. LNEPs maintained as above were dissociated and re-plated directly into SAGM baseline media with added DAPT or GSI-X (Calbiochem) at 40 or 20 mM concentrations (unless otherwise indicated). 
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Extended Data Figure 5 | Heterogeneity of the LNEP-containing CC10 2 b 4 1 population. a, Rare Krt5-CreERT2-traced (tdTomato 1 ) cells were observed in uninjured distal lung airways that lacked Krt5 staining compared to trachea basal cells (inset) in the same section. All distal tdTomato 1 cells express DNp63 but most DNp63 1 cells are untraced (see Fig. 2c ). b, Cytospins of sorted CC10 2 b 4 1 cells reveal the presence of abundant multiciliated cells (green, acetylated tubulin 1 ) and a small fraction of DNp63 1 cells (red). c, Quantitative reverse transcriptase PCR (qRT-PCR) analysis of mature lineage genes and genes of interest in all populations. n 5 3 biological replicates; data are mean 6 s.d. d, Principal component analysis plot of cells sequenced in Fig. 2b , demonstrating that p63 1 cells in the CC10 2 b 4 1 population (outlined, asterisk) cluster with multi-ciliated cells. e, CD200 is not expressed by FoxJ1-CreERT2-labelled multi-ciliated cells, highlighting its use in excluding such cells. f, Cytospin of Foxj1-CreERT2-labelled b 4 1 cells demonstrating reliable selection for multi-ciliated cells (198 cells quantified). g, Gating on CD14 expression within the EpCAM 1 b 4 1 CD200 1 population excludes CC10-expressing club cells. Scale bars, 20 mm.
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